Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. But that’s been changing over the past few years and is likely to continue to grow moving forward.
On April 23 a group led by private equity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 billion. AmerisourceBergen, the big drug wholesaler, is buying a minority stake in the firm; OneOncology’s affiliated practices, physicians, and management team will also retain a minority interest.
In the fast-paced world of e-commerce, staying ahead of the ...
The ophthalmology sector continues to be a robust market entering Q2 2023. There are more than 25 core private equity platforms within ophthalmology, plus smaller regional PE-backed groups. Read more here.
Ten years ago, many of the tasks in a high-precision ...
In 2021 FOCUS had its most successful year. We saw tremendous growth in the number of transactions we completed as well as the revenue we generated. We invite you to read our Year In Review.
Determining the ROI of welding robots on an assembly line is a complex math task.
New Platform investments are the life blood of private equity, as they are viewed as the starting point for more acquisitions in the future.
Strategic “Add-Ons” are designed to complement an existing platform business.
M&A Worldwide recently conducted an interview with two bankers from FOCUS Investment Banking to gain insight into the practice and workings of the Advanced Manufacturing sector.
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC
© 2024 FOCUS Investment Banking LLC
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC
Member of M&A Worldwide 
